Literature DB >> 9826690

An artificial cell-cycle inhibitor isolated from a combinatorial library.

B A Cohen1, P Colas, R Brent.   

Abstract

Understanding the genetic networks that operate inside cells will require the dissection of interactions among network members. Here we describe a peptide aptamer isolated from a combinatorial library that distinguishes among such interactions. This aptamer binds to cyclin-dependent kinase 2 (Cdk2) and inhibits its kinase activity. In contrast to naturally occurring inhibitors, such as p21(Cip1), which inhibit the activity of Cdk2 on all its substrates, inhibition by pep8 has distinct substrate specificity. We show that the aptamer binds to Cdk2 at or near its active site and that its mode of inhibition is competitive. Expression of pep8 in human cells retards their progression through the G1 phase of the cell cycle. Our results suggest that the aptamer inhibits cell-cycle progression by blocking the activity of Cdk2 on substrates needed for the G1-to-S transition. This work demonstrates the feasibility of selection of artificial proteins to perform functions not developed during evolution. The ability to select proteins that block interactions between a gene product and some partners but not others should make sophisticated genetic manipulations possible in human cells and other currently intractable systems.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9826690      PMCID: PMC24363          DOI: 10.1073/pnas.95.24.14272

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

Review 1.  Knockouts. Targeting the mouse genome: a compendium of knockouts (Part I)

Authors:  E P Brandon; R L Idzerda; G S McKnight
Journal:  Curr Biol       Date:  1995-06-01       Impact factor: 10.834

2.  A bacterial repressor protein or a yeast transcriptional terminator can block upstream activation of a yeast gene.

Authors:  R Brent; M Ptashne
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

3.  Physical interaction of the retinoblastoma protein with human D cyclins.

Authors:  S F Dowdy; P W Hinds; K Louie; S I Reed; A Arnold; R A Weinberg
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

4.  Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle.

Authors:  A Koff; A Giordano; D Desai; K Yamashita; J W Harper; S Elledge; T Nishimoto; D O Morgan; B R Franza; J M Roberts
Journal:  Science       Date:  1992-09-18       Impact factor: 47.728

5.  Functional interactions of the retinoblastoma protein with mammalian D-type cyclins.

Authors:  M E Ewen; H K Sluss; C J Sherr; H Matsushime; J Kato; D M Livingston
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

6.  Association of human cyclin E with a periodic G1-S phase protein kinase.

Authors:  V Dulić; E Lees; S I Reed
Journal:  Science       Date:  1992-09-25       Impact factor: 47.728

7.  Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library.

Authors:  K T O'Neil; R H Hoess; S A Jackson; N S Ramachandran; S A Mousa; W F DeGrado
Journal:  Proteins       Date:  1992-12

8.  Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex.

Authors:  P D Jeffrey; A A Russo; K Polyak; E Gibbs; J Hurwitz; J Massagué; N P Pavletich
Journal:  Nature       Date:  1995-07-27       Impact factor: 49.962

9.  Inhibition of cyclin-dependent kinases by p21.

Authors:  J W Harper; S J Elledge; K Keyomarsi; B Dynlacht; L H Tsai; P Zhang; S Dobrowolski; C Bai; L Connell-Crowley; E Swindell
Journal:  Mol Biol Cell       Date:  1995-04       Impact factor: 4.138

Review 10.  M13 bacteriophage displaying disulfide-constrained microproteins.

Authors:  M A McLafferty; R B Kent; R C Ladner; W Markland
Journal:  Gene       Date:  1993-06-15       Impact factor: 3.688

View more
  25 in total

1.  "Mutagenesis" by peptide aptamers identifies genetic network members and pathway connections.

Authors:  C R Geyer; A Colman-Lerner; R Brent
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

2.  Targeted modification and transportation of cellular proteins.

Authors:  P Colas; B Cohen; P Ko Ferrigno; P A Silver; R Brent
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

3.  TEM-1 beta-lactamase as a scaffold for protein recognition and assay.

Authors:  Daniel Legendre; Bénédicte Vucic; Vincent Hougardy; Anne-Lise Girboux; Christophe Henrioul; Julien Van Haute; Patrice Soumillion; Jacques Fastrez
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

4.  p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein.

Authors:  S Shintani; H Ohyama; X Zhang; J McBride; K Matsuo; T Tsuji; M G Hu; G Hu; Y Kohno; M Lerman; R Todd; D T Wong
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

5.  Ligand-regulated peptide aptamers that inhibit the 5'-AMP-activated protein kinase.

Authors:  Russell A Miller; Brock F Binkowski; Peter J Belshaw
Journal:  J Mol Biol       Date:  2006-07-26       Impact factor: 5.469

6.  Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein.

Authors:  K Butz; C Denk; A Ullmann; M Scheffner; F Hoppe-Seyler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

7.  Targeting cyclin-dependent kinases in Drosophila with peptide aptamers.

Authors:  M G Kolonin; R L Finley
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

8.  Intracellular expression of Peptide fusions for demonstration of protein essentiality in bacteria.

Authors:  R Edward Benson; Elizabeth B Gottlin; Dale J Christensen; Paul T Hamilton
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

9.  Structure-function studies of an engineered scaffold protein derived from stefin A. I: Development of the SQM variant.

Authors:  Toni Hoffmann; Lukas Kurt Josef Stadler; Michael Busby; Qifeng Song; Anthony T Buxton; Simon D Wagner; Jason J Davis; Paul Ko Ferrigno
Journal:  Protein Eng Des Sel       Date:  2010-02-23       Impact factor: 1.650

10.  Peptide aptamers as new tools to modulate clathrin-mediated internalisation--inhibition of MT1-MMP internalisation.

Authors:  Rochana D Wickramasinghe; Paul Ko Ferrigno; Christian Roghi
Journal:  BMC Cell Biol       Date:  2010-07-23       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.